| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |